NOVARTIS - Reinventing Feasibility from Static Planning to Continuous Decision Support

Session details:

Novartis reports on its 2+ year journey to modernize feasibility and early trial planning—starting with decision ownership and operating model clarity, then advancing to an AI‑enabled “computational twin” that supports continuous, data‑driven planning and trade‑offs across the asset lifecycle.

• Why an AI‑agnostic foundation was critical to making advanced decision support effective and scalable

• How feasibility is evolving from a one‑time checkpoint into a continuous, lifecycle‑based decision capability
• Early lessons on what it takes—organizationally and culturally—to support faster planning, better trade‑offs, and more informed asset decisions